Novum Pharmaceutical Research Services has an immediate need for a Full Time Medical Monitor
The Medical Monitor will be responsible for supervising and coordinating all medical issues related to studies managed by the Division of Clinical Trials. Will provide medical guidance and consultation to the Clinical Research Associates, Scientific Staff, Project Managers, Investigator Sites and Sponsors on the design implementation, conduct and reporting of research studies.
Successful candidate will have a Doctoral degree (MD or DO), ability to travel up to 25%, and excellent written/verbal communication skills. Clinical research experience is preferred.
This terrific opportunity is conveniently located in our beautiful corporate offices in Pittsburgh’s Station Square. APPLY TODAY!
About Novum Pharmaceutical Research Services
Novum is a contract research organization ("CRO") that provides clinical research, data management, statistical and reporting services to the pharmaceutical and related industries. Novum was founded in 1972 and operates Phase I research facilities with a total of 550 beds in three USA locations. Novum is the second largest CRO in the USA as, measured in bed capacity. Novum averages over 200 Phase I studies performed annually.
Novum maintains a highly-experienced management team and staff with the capabilities to perform a wide range of Phase I clinical trials. Although most Phase I studies are conducted with oral dosage formulations, Novum has developed expertise in performing studies with non-traditional delivery systems such as topical transdermal, nasal, inhaled, rectal, vaginal, and intravenous routes of administration. Novum is the world leader in vasoconstrictor studies of topical corticosteroids for both generic and innovator drugs. Further, we are a leader in performing pharmocokinetic (PK), irritation, sensitization, and adhesion studies with transdermal and topical dosage forms.
Novum’s rapidly growing clinical trials management and data management groups, cu...rrently focus on performing Phase II through IV clinical endpoint studies requiring large patient populations in non-serious disease states that are treated in an outpatient setting. Examples would include for example many dermatological diseases, allergies, vaccines and diabetes.